Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
Phase 3
- Conditions
- acute myelocytic leukemia
- Registration Number
- JPRN-C000000220
- Lead Sponsor
- Japan Adult Leukemia Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 288
Inclusion Criteria
Not provided
Exclusion Criteria
History of acute myocardial infarction within 1 year History of renal insuficiancy Poorly controlled diabetes Poorly controleed angina Uncontrolled active infection Liver cirrohsis Severe psychiatric disease Positive for HIV antibody Positive for HCV antibody Positive for HBs antigen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complete remission rate, survival period
- Secondary Outcome Measures
Name Time Method over all survival rate, event-free survival